These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28019699)

  • 41. Mutagenesis reveals a role for epidermal growth factor receptor extracellular subdomain IV in ligand binding.
    Saxon ML; Lee DC
    J Biol Chem; 1999 Oct; 274(40):28356-62. PubMed ID: 10497195
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Conformational nanobodies reveal tethered epidermal growth factor receptor involved in EGFR/ErbB2 predimers.
    Nevoltris D; Lombard B; Dupuis E; Mathis G; Chames P; Baty D
    ACS Nano; 2015 Feb; 9(2):1388-99. PubMed ID: 25603171
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The membrane-proximal intracellular domain of the epidermal growth factor receptor underlies negative cooperativity in ligand binding.
    Adak S; Yang KS; Macdonald-Obermann J; Pike LJ
    J Biol Chem; 2011 Dec; 286(52):45146-55. PubMed ID: 22069315
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Architecture and membrane interactions of the EGF receptor.
    Arkhipov A; Shan Y; Das R; Endres NF; Eastwood MP; Wemmer DE; Kuriyan J; Shaw DE
    Cell; 2013 Jan; 152(3):557-69. PubMed ID: 23374350
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Non-Ligand-Induced Dimerization is Sufficient to Initiate the Signalling and Endocytosis of EGF Receptor.
    Kourouniotis G; Wang Y; Pennock S; Chen X; Wang Z
    Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27463710
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The epidermal growth factor.
    Boonstra J; Rijken P; Humbel B; Cremers F; Verkleij A; van Bergen en Henegouwen P
    Cell Biol Int; 1995 May; 19(5):413-30. PubMed ID: 7640657
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heterodimerization of the epidermal-growth-factor (EGF) receptor and ErbB2 and the affinity of EGF binding are regulated by different mechanisms.
    Johannessen LE; Haugen KE; østvold AC; Stang E; Madshus IH
    Biochem J; 2001 May; 356(Pt 1):87-96. PubMed ID: 11336639
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CR1/CR2 interactions modulate the functions of the cell surface epidermal growth factor receptor.
    Walker F; Orchard SG; Jorissen RN; Hall NE; Zhang HH; Hoyne PA; Adams TE; Johns TG; Ward C; Garrett TP; Zhu HJ; Nerrie M; Scott AM; Nice EC; Burgess AW
    J Biol Chem; 2004 May; 279(21):22387-98. PubMed ID: 15016810
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of the N-terminus of epidermal growth factor in ErbB-2/ErbB-3 binding studied by phage display.
    Stortelers C; Souriau C; van Liempt E; van de Poll ML; van Zoelen EJ
    Biochemistry; 2002 Jul; 41(27):8732-41. PubMed ID: 12093292
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Real-time kinetic studies on the interaction of transforming growth factor alpha with the epidermal growth factor receptor extracellular domain reveal a conformational change model.
    De Crescenzo G; Grothe S; Lortie R; Debanne MT; O'Connor-McCourt M
    Biochemistry; 2000 Aug; 39(31):9466-76. PubMed ID: 10924142
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Profiling epidermal growth factor receptor and heregulin receptor 3 heteromerization using receptor tyrosine kinase heteromer investigation technology.
    Ayoub MA; See HB; Seeber RM; Armstrong SP; Pfleger KD
    PLoS One; 2013; 8(5):e64672. PubMed ID: 23700486
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular dynamics simulations of transitions for ECD epidermal growth factor receptors show key differences between human and drosophila forms of the receptors.
    Perilla JR; Leahy DJ; Woolf TB
    Proteins; 2013 Jul; 81(7):1113-26. PubMed ID: 23348956
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Post-translational acquisition of ligand binding- and tyrosine kinase-domain function by the epidermal growth factor and insulin receptors.
    Lane MD; Slieker LJ; Olson TS; Martensen TM
    J Recept Res; 1987; 7(1-4):321-54. PubMed ID: 3305909
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Negative co-operativity in the EGF receptor.
    Pike LJ
    Biochem Soc Trans; 2012 Feb; 40(1):15-9. PubMed ID: 22260659
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A structure-based model for ligand binding and dimerization of EGF receptors.
    Klein P; Mattoon D; Lemmon MA; Schlessinger J
    Proc Natl Acad Sci U S A; 2004 Jan; 101(4):929-34. PubMed ID: 14732694
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transmembrane signaling by epidermal growth factor receptors lacking autophosphorylation sites.
    Decker SJ
    J Biol Chem; 1993 May; 268(13):9176-9. PubMed ID: 8387484
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structural basis for EGFR ligand sequestration by Argos.
    Klein DE; Stayrook SE; Shi F; Narayan K; Lemmon MA
    Nature; 2008 Jun; 453(7199):1271-5. PubMed ID: 18500331
    [TBL] [Abstract][Full Text] [Related]  

  • 58. EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization.
    Ferguson KM; Berger MB; Mendrola JM; Cho HS; Leahy DJ; Lemmon MA
    Mol Cell; 2003 Feb; 11(2):507-17. PubMed ID: 12620237
    [TBL] [Abstract][Full Text] [Related]  

  • 59. On the nature of low- and high-affinity EGF receptors on living cells.
    Ozcan F; Klein P; Lemmon MA; Lax I; Schlessinger J
    Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5735-40. PubMed ID: 16571657
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Simulation of homology models for the extracellular domains (ECD) of ErbB3, ErbB4 and the ErbB2-ErbB3 complex in their active conformations.
    Franco-Gonzalez JF; Ramos J; Cruz VL; Martínez-Salazar J
    J Mol Model; 2013 Feb; 19(2):931-41. PubMed ID: 23090500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.